From Polar park. Luckily there is a solid fence between us and the bear

Stocks Are Now Overbought And Ready To Pull Back on August 31

This column is my opinion and expresses my views. Those views can change at a moments notice when the market changes. I am not right all the time and I do not expect to be. I disclose all my positions clearly listed on the page, and I do not trade my account on the stocks spoken of in this column unless fully disclosed. If that does not work for you stop reading and close the page. Do not bother me or harass me.

Otherwise, enjoy the column!

Subscribe to the Monster Stock Market Commentary and join the 2,516 subscribers getting it for FREE every day!

STOCKS – ZM, MA, AMZN, MU

MACRO – SPY, QQQ, IEF

Mike’s Reading The Markets (RTM) Premium Content – PRICES RISING ON SEPTEMBER 7 TO $45/MONTH FROM $35 OR $400/YEAR FROM $300, LOCK IN THE LOWER RATE NOW AND ALSO GET THE FIRST TWO-WEEKS FREE TO TRY IT OUT.

MICHAEL KRAMER AND THE CLIENTS OF MOTT CAPITAL OWN MA

Stocks finished the day mostly higher, with the S&P 500 up roughly 40 bps. Despite the positive day, the advance/decline line fell and has not confirmed any of the new highs for the S&P 500 since the A/D line peaked at the beginning of July. Regardless the S&P 500 is now trading above its upper Bollinger band, indicating it is over-bought. The pattern has been to reverse and retrace back to the lower Bollinger band, which is around 4,390.

The Qs are overbought based on the Bollinger band and the RSI, based on those two indicators. That would also indicate that the Qs retrace, again potentially to their lower band around $360.

Meanwhile, the NASDAQ Comp. advance-decline line also fell and hasn’t seen a high since the end of June.

The 10-year fell slightly today, but the RSI is still trending higher, indicating yields can climb from here over the very short term.

Zoom (ZM)

Zoom is getting crushed tonight, which is what happens when you give inline revenue guidance and then disappoint on the earnings guidance, and you trade at 70 times 2024 earnings estimates and 18 times sales. As I have said multiple times, the company is not growing fast enough to fit into its valuation. When a growth stock with a high valuation disappoints, it is toast; it will be dead money until the company reports next quarter, just like Amazon. There is no room for error.

The double top pattern should easily get confirmed tomorrow, with support at $280. Yeah, I know all those price targets are around $425; yeah, watch how they start getting cut.

 

Amazon (AMZN)

Speaking of Amazon, it rallied some 2% today, making it back to its upper Bollinger band, and just a hair below its 50-day moving average. It could fill the gap at 3,600. I don’t see any reason why it should, given the terrible guidance they gave when they reported results a few weeks ago. My guess is we see $3,300 before $3,600.

Mastercard (MA)

It is a little concerning that Mastercard fell below its 200-day moving average and looks like it is really breaking down. I hope it can hold on to support around $350, but it isn’t looking good at this point. If $350 goes, we are probably looking for $325.

Micron (MU)

We can finish with Micron because everyone got excited last and thought the stock was going higher. It was pretty clear it wasn’t going higher because it failed intraday at the 50-day moving average. The momentum is going all the wrong, and I still think the stock sees $58 before it sees $86.

Mike

Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and, unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future results.